ATE359774T1 - Taurinderivate verwendbar in der behandlung von netzhauterkrankungen - Google Patents

Taurinderivate verwendbar in der behandlung von netzhauterkrankungen

Info

Publication number
ATE359774T1
ATE359774T1 AT98962016T AT98962016T ATE359774T1 AT E359774 T1 ATE359774 T1 AT E359774T1 AT 98962016 T AT98962016 T AT 98962016T AT 98962016 T AT98962016 T AT 98962016T AT E359774 T1 ATE359774 T1 AT E359774T1
Authority
AT
Austria
Prior art keywords
methods
taurine derivatives
nonatetraen
cyclohexen
imido
Prior art date
Application number
AT98962016T
Other languages
English (en)
Inventor
Andranik M Petrosian
Jasmine E Haroutounian
Armen Vartanian
Original Assignee
Karageozian Hampar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karageozian Hampar filed Critical Karageozian Hampar
Application granted granted Critical
Publication of ATE359774T1 publication Critical patent/ATE359774T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98962016T 1997-12-10 1998-12-09 Taurinderivate verwendbar in der behandlung von netzhauterkrankungen ATE359774T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/982,249 US6391924B1 (en) 1997-12-10 1997-12-10 Taurine derivatives useable in the treatment of ophthalmic disorders

Publications (1)

Publication Number Publication Date
ATE359774T1 true ATE359774T1 (de) 2007-05-15

Family

ID=25528983

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98962016T ATE359774T1 (de) 1997-12-10 1998-12-09 Taurinderivate verwendbar in der behandlung von netzhauterkrankungen

Country Status (9)

Country Link
US (1) US6391924B1 (de)
EP (1) EP1037622B1 (de)
JP (1) JP2001525362A (de)
CN (1) CN1191827C (de)
AT (1) ATE359774T1 (de)
CA (1) CA2312842C (de)
DE (1) DE69837622T2 (de)
ES (1) ES2286864T3 (de)
WO (1) WO1999029315A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10035620B4 (de) * 2000-07-21 2005-07-14 *Acri.Tec Gesellschaft für ophthalmologische Produkte mbH Verwendung von Taurin als neuroprotektives Agens in der Ophthalmologie
EP2327400A3 (de) 2003-03-14 2011-10-19 University of Washington Retinoid-ersatz und opsin-agonisten und anwendungsverfahren dafür
SI1765322T1 (sl) 2004-06-18 2014-03-31 University Of Washington Intellectual Property And Technology Transfer 4311 Derivati retinala in postopki za njihovo uporabo za zdravljenje motenj vida
WO2009102418A1 (en) 2008-02-11 2009-08-20 University Of Washington Methods for the treatment and prevention of age-related retinal dysfunction
AU2015200520B2 (en) * 2008-02-11 2017-02-09 University Of Washington Methods for the treatment and prevention of age-related retinal dysfunction
AU2009352678B2 (en) 2009-09-15 2015-05-21 Eluminex Biosciences (Suzhou) Limited Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle
EP2563350B1 (de) 2010-04-19 2020-10-14 Retinagenix Therapeutics, Inc. Therapieplan und verfahren zur behandlung oder linderung von mit einer endogenen netzhautschwäche assoziierten sehstörungen
BR112014021602A2 (pt) 2012-03-01 2021-06-08 Quadra Logic Tech Inc uso, kit e derivado de retinal sintético para melhorar a função visual em distúrbios visuais associados com a deficiência de produção endógena de retinóide
CN103720641A (zh) * 2013-11-25 2014-04-16 中国中医科学院中药研究所 牛磺酸眼用在体凝胶制剂及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0680964A (ja) * 1991-12-27 1994-03-22 Sogo Yatsukou Kk 活性酸素消去剤

Also Published As

Publication number Publication date
CN1191827C (zh) 2005-03-09
US6391924B1 (en) 2002-05-21
DE69837622T2 (de) 2008-01-03
DE69837622D1 (de) 2007-05-31
JP2001525362A (ja) 2001-12-11
EP1037622B1 (de) 2007-04-18
CN1290162A (zh) 2001-04-04
CA2312842C (en) 2010-03-09
WO1999029315A1 (en) 1999-06-17
ES2286864T3 (es) 2007-12-01
EP1037622A1 (de) 2000-09-27
CA2312842A1 (en) 1999-06-17
EP1037622A4 (de) 2002-11-06

Similar Documents

Publication Publication Date Title
ES2152556T3 (es) Composiciones que contienen derivados del acido hidroperoxieicosatetraenoico y procedimientos de utilizacion en el tratamiento de trastornos de la sequedad ocular.
ATE322283T1 (de) Transdermale verwendung von sekretin zur behandlung von autismus
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
PT868186E (pt) Utilizacao de certos compostos de isoquinolinossulfonilo para tratamento de glaucoma e isquemia ocular
DE69521620D1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
ATE319474T1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
ATE420857T1 (de) Prostaglandin-derivate zur behandlung von glaukom und ocularer hypertension
ES482097A1 (es) Procedimiento para preparar derivados acilicos de carnitina.
ATE365550T1 (de) Verwendung von einem protein kinase hemmer wie z.b. genistein bei der behandlung von diabetischer retinopathie
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
EA200300560A1 (ru) Улучшенный способ лечения
TR200400526T4 (tr) Göz kurumasının tedavisi için lipoksin A4 ve analogları
DE69613693D1 (de) 2-heteroarylalkenylderivate der cyclopentano-heptan(heptaen)säure als therapeutisches mittel zur behandlung des erhöhten augeninnendruckes
DE69930271D1 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
DE60130872D1 (de) Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer
ATE359774T1 (de) Taurinderivate verwendbar in der behandlung von netzhauterkrankungen
TR199700711T1 (xx) Ciltten ge�erek v�cuda giren form�lasyon.
ATE128141T1 (de) Als therapeutische mittel verwendbare substituierte adeninderivate.
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
DE69534620D1 (de) Verfahren zur behandlung von augenerkrankungen
NO20044530L (no) Fremgangsmate for behandling av kognitive forstyrrelser
PT986393E (pt) Utilizacao de um nitroxido ou de um seu pro-farmaco no tratamento profilactico e terapeutico do cancro
DE69013431D1 (de) Anthocyanidine zur Behandlung von Augenkrankheiten.
BR0113201A (pt) processo para tratar distúrbios neurodegenerativos da retina e da cabeça do nervo óptico
BR9915803A (pt) Composição para o tratamento de neuropatia da retina ou cabeça de nervo ótico, e, processo para tratamento de neuropatia da retina ou cabeça de nervo ótico

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties